27.03.2013 • News • Recipharm • pharmaceutical industry • Pharmaceuticals

Recipharm Site Approved for Supply of Manufactured Products to Japan

Recipharm's solid dose facility located in Fontaine, France, has been approved for supply of manufactured products to the Japan's pharmaceuticals market following a recent inspection by the PMDA, the Japanese drug agency.

The product dossier was presented by an existing contract manufacturing customer, also securing regulatory approval for its supply to Japan.

The Fontaine site is one of Recipharm's solid dose forms site and until 2009 was owned by Solvay Pharma (now Abbott). The facility is also approved to supply to the US. In addition to manufacturing, the site also has a distribution centre for delivery to pharmacy level within France.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.